UBS Group’s iPath Pure Beta Lead ETN LEDD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-653
Closed -$26K 8607
2018
Q1
$26K Hold
653
﹤0.01% 6238
2017
Q4
$27K Buy
653
+6
+0.9% +$252 ﹤0.01% 6344
2017
Q3
$26K Sell
647
-593
-48% -$22.9K ﹤0.01% 6287
2017
Q2
$47K Hold
1,240
﹤0.01% 5702
2017
Q1
$48K Buy
1,240
+218
+21% +$8.31K ﹤0.01% 5560
2016
Q4
$34K Sell
1,022
-502
-33% -$18.5K ﹤0.01% 6149
2016
Q3
$54K Sell
1,524
-2
-0.1% -$64 ﹤0.01% 5458
2016
Q2
$46K Hold
1,526
﹤0.01% 5590
2016
Q1
$44K Buy
1,526
+191
+14% +$5.82K ﹤0.01% 5603
2015
Q4
$40K Sell
1,335
-200
-13% -$5.72K ﹤0.01% 6045
2015
Q3
$44K Buy
1,535
+9
+0.6% +$266 ﹤0.01% 5958
2015
Q2
$46K Buy
1,526
+95
+7% +$3.15K ﹤0.01% 6076
2015
Q1
$44K Hold
1,431
﹤0.01% 6183
2014
Q4
$46K Buy
+1,431
New +$50.7K ﹤0.01% 6597

UBS Group's LEDD Position: Q2 2018 in Review

UBS Group sold out of iPath Pure Beta Lead ETN (LEDD) in Q2 2018, closing a stake of 653 shares — an estimated $26K sold.

UBS Group first reported a position in LEDD in Q4 2014 and held it in 14 quarters. The position peaked at $54K in Q3 2016. 0 funds tracked by Wall St. Rank hold LEDD as of Q2 2018.

  • UBS Group reported no remaining iPath Pure Beta Lead ETN position as of Q2 2018 after selling out during the quarter.
  • UBS Group sold 653 iPath Pure Beta Lead ETN shares in Q2 2018, an estimated $26K.
  • UBS Group first reported a position in iPath Pure Beta Lead ETN in Q4 2014 and held it in 14 quarters.
  • UBS Group's iPath Pure Beta Lead ETN position peaked at $54K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held iPath Pure Beta Lead ETN as of Q2 2018.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.